FDAnews
www.fdanews.com/articles/146445-celsion-announces-resubmission-with-philips-healthcare-of-combined-ind-ide-application-for-a-phase-ii-study-of-thermodox-mr-guided-hifu-in-bone-cancer

Celsion Announces Resubmission With Philips Healthcare of Combined IND/IDE Application for a Phase II Study of ThermoDox, MR-Guided HIFU in Bone Cancer

May 15, 2012
Celsion announced a joint resubmission with Philips Healthcare of an IND/IDE application with the FDA for a Phase II clinical study of Celsion’s ThermoDox combined with Philips’ Sonalleve MR-HIFU technology for the treatment of prostate cancer metastases to the bone.
SYS-CON Media